High levels of Zinc-α-2-Glycoprotein among Omani AIDS patients on combined antiretroviral therapy

Sidgi Syed Anwer Hasson, Mohammed Saeed Al-Balushi, Muzna Hamed Al Yahmadi, Juma Zaid Al-Busaidi, Elias Antony Said, Mohammed Shafeeq Othman, Talal Abdullah Sallam, Mohammed Ahmad Idris, Ali Abdullah Al-Jabri

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To investigate the levels of zinc-α-2-glycoprotein (ZAG) among Omani AIDS patients receiving combined antiretroviral therapy (cART). Methods: A total of 80 Omani AIDS patients (45 males and 35 females), average age of 36 years, who were receiving cART at the Sultan Qaboos University Hospital (SQUH), Muscat, Oman, were tested for the levels of ZAG. In addition, 80 healthy blood donors (46 males and 34 females), average age of 26 years, attending the SQUH Blood Bank, were tested in parallel as a control group. Measurement of the ZAG levels was performed using a competitive enzyme-linked immunosorbent assay and in accordance with the manufacturer's instructions. Results: The ZAG levels were found to be significantly higher among AIDS patients compared to the healthy individuals (P=0.033). A total of 56 (70%) of the AIDS patients were found to have higher levels of ZAG and 16 (20%) AIDS patients were found to have high ZAG levels, which are significantly (P > 0.031) associated with weight loss. Conclusions: ZAG levels are high among Omani AIDS patients on cART and this necessitates the measurement of ZAG on routine basis, as it is associated with weight loss.

Original languageEnglish
Pages (from-to)610-613
Number of pages4
JournalAsian Pacific Journal of Tropical Biomedicine
Volume4
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Zinc
Glycoproteins
Acquired Immunodeficiency Syndrome
Blood
Immunosorbents
Assays
Weight Loss
Enzymes
Therapeutics
Oman
Blood Banks
Blood Donors
Sultan
Enzyme-Linked Immunosorbent Assay
Control Groups

Keywords

  • AIDS
  • Combined antiretroviral therapy
  • Levels
  • Oman
  • Patients
  • Zinc-α-2-glycoprotein

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

Cite this

High levels of Zinc-α-2-Glycoprotein among Omani AIDS patients on combined antiretroviral therapy. / Hasson, Sidgi Syed Anwer; Al-Balushi, Mohammed Saeed; Al Yahmadi, Muzna Hamed; Al-Busaidi, Juma Zaid; Said, Elias Antony; Othman, Mohammed Shafeeq; Sallam, Talal Abdullah; Idris, Mohammed Ahmad; Al-Jabri, Ali Abdullah.

In: Asian Pacific Journal of Tropical Biomedicine, Vol. 4, No. 8, 2014, p. 610-613.

Research output: Contribution to journalArticle

@article{ff5d067b880e4017983737345a58a2b0,
title = "High levels of Zinc-α-2-Glycoprotein among Omani AIDS patients on combined antiretroviral therapy",
abstract = "Objective: To investigate the levels of zinc-α-2-glycoprotein (ZAG) among Omani AIDS patients receiving combined antiretroviral therapy (cART). Methods: A total of 80 Omani AIDS patients (45 males and 35 females), average age of 36 years, who were receiving cART at the Sultan Qaboos University Hospital (SQUH), Muscat, Oman, were tested for the levels of ZAG. In addition, 80 healthy blood donors (46 males and 34 females), average age of 26 years, attending the SQUH Blood Bank, were tested in parallel as a control group. Measurement of the ZAG levels was performed using a competitive enzyme-linked immunosorbent assay and in accordance with the manufacturer's instructions. Results: The ZAG levels were found to be significantly higher among AIDS patients compared to the healthy individuals (P=0.033). A total of 56 (70{\%}) of the AIDS patients were found to have higher levels of ZAG and 16 (20{\%}) AIDS patients were found to have high ZAG levels, which are significantly (P > 0.031) associated with weight loss. Conclusions: ZAG levels are high among Omani AIDS patients on cART and this necessitates the measurement of ZAG on routine basis, as it is associated with weight loss.",
keywords = "AIDS, Combined antiretroviral therapy, Levels, Oman, Patients, Zinc-α-2-glycoprotein",
author = "Hasson, {Sidgi Syed Anwer} and Al-Balushi, {Mohammed Saeed} and {Al Yahmadi}, {Muzna Hamed} and Al-Busaidi, {Juma Zaid} and Said, {Elias Antony} and Othman, {Mohammed Shafeeq} and Sallam, {Talal Abdullah} and Idris, {Mohammed Ahmad} and Al-Jabri, {Ali Abdullah}",
year = "2014",
doi = "10.12980/APJTB.4.201414B126",
language = "English",
volume = "4",
pages = "610--613",
journal = "Asian Pacific Journal of Tropical Biomedicine",
issn = "2221-1691",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - High levels of Zinc-α-2-Glycoprotein among Omani AIDS patients on combined antiretroviral therapy

AU - Hasson, Sidgi Syed Anwer

AU - Al-Balushi, Mohammed Saeed

AU - Al Yahmadi, Muzna Hamed

AU - Al-Busaidi, Juma Zaid

AU - Said, Elias Antony

AU - Othman, Mohammed Shafeeq

AU - Sallam, Talal Abdullah

AU - Idris, Mohammed Ahmad

AU - Al-Jabri, Ali Abdullah

PY - 2014

Y1 - 2014

N2 - Objective: To investigate the levels of zinc-α-2-glycoprotein (ZAG) among Omani AIDS patients receiving combined antiretroviral therapy (cART). Methods: A total of 80 Omani AIDS patients (45 males and 35 females), average age of 36 years, who were receiving cART at the Sultan Qaboos University Hospital (SQUH), Muscat, Oman, were tested for the levels of ZAG. In addition, 80 healthy blood donors (46 males and 34 females), average age of 26 years, attending the SQUH Blood Bank, were tested in parallel as a control group. Measurement of the ZAG levels was performed using a competitive enzyme-linked immunosorbent assay and in accordance with the manufacturer's instructions. Results: The ZAG levels were found to be significantly higher among AIDS patients compared to the healthy individuals (P=0.033). A total of 56 (70%) of the AIDS patients were found to have higher levels of ZAG and 16 (20%) AIDS patients were found to have high ZAG levels, which are significantly (P > 0.031) associated with weight loss. Conclusions: ZAG levels are high among Omani AIDS patients on cART and this necessitates the measurement of ZAG on routine basis, as it is associated with weight loss.

AB - Objective: To investigate the levels of zinc-α-2-glycoprotein (ZAG) among Omani AIDS patients receiving combined antiretroviral therapy (cART). Methods: A total of 80 Omani AIDS patients (45 males and 35 females), average age of 36 years, who were receiving cART at the Sultan Qaboos University Hospital (SQUH), Muscat, Oman, were tested for the levels of ZAG. In addition, 80 healthy blood donors (46 males and 34 females), average age of 26 years, attending the SQUH Blood Bank, were tested in parallel as a control group. Measurement of the ZAG levels was performed using a competitive enzyme-linked immunosorbent assay and in accordance with the manufacturer's instructions. Results: The ZAG levels were found to be significantly higher among AIDS patients compared to the healthy individuals (P=0.033). A total of 56 (70%) of the AIDS patients were found to have higher levels of ZAG and 16 (20%) AIDS patients were found to have high ZAG levels, which are significantly (P > 0.031) associated with weight loss. Conclusions: ZAG levels are high among Omani AIDS patients on cART and this necessitates the measurement of ZAG on routine basis, as it is associated with weight loss.

KW - AIDS

KW - Combined antiretroviral therapy

KW - Levels

KW - Oman

KW - Patients

KW - Zinc-α-2-glycoprotein

UR - http://www.scopus.com/inward/record.url?scp=84922650280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922650280&partnerID=8YFLogxK

U2 - 10.12980/APJTB.4.201414B126

DO - 10.12980/APJTB.4.201414B126

M3 - Article

VL - 4

SP - 610

EP - 613

JO - Asian Pacific Journal of Tropical Biomedicine

JF - Asian Pacific Journal of Tropical Biomedicine

SN - 2221-1691

IS - 8

ER -